Strata Skin Sciences Profit Margin 2010-2023 | SSKN
Current and historical gross margin, operating margin and net profit margin for Strata Skin Sciences (SSKN) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Strata Skin Sciences net profit margin as of September 30, 2023 is -32.47%.
| Strata Skin Sciences Annual Profit Margins |
|---|
| Strata Skin Sciences Quarterly Profit Margins |
|---|
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.018B | $0.033B |
| Strata Skin Sciences, Inc. is a medical technology company which focused on the dermatology market. Its products include the XTRAC laser(R) and VTRAC(R) excimer lamp systems for treatment of psoriasis, vitiligo and other skin conditions as well as the MelaFind (R) system used for identification and management of melanoma skin cancer. Strata Skin Sciences, Inc., formerly known as MELA Sciences, Inc., is based in Horsham, Pennsylvania. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GE HealthCare Technologies (GEHC) | United States | $39.372B | 21.90 |
| Inspire Medical Systems (INSP) | United States | $7.021B | 0.00 |
| 10x Genomics (TXG) | United States | $4.117B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $3.520B | 0.00 |
| Axonics (AXNX) | United States | $3.448B | 0.00 |
| Enovis (ENOV) | United States | $3.211B | 24.40 |
| Azenta (AZTA) | United States | $3.053B | 248.86 |
| Hims & Hers Health (HIMS) | United States | $2.991B | 0.00 |
| Olink Holding AB (publ) (OLK) | Sweden | $2.838B | 0.00 |
| Privia Health (PRVA) | United States | $2.200B | 97.58 |
| Schrodinger (SDGR) | United States | $1.913B | 0.00 |
| Phreesia (PHR) | United States | $1.330B | 0.00 |
| Omnicell (OMCL) | United States | $1.248B | 30.54 |
| Definitive Healthcare (DH) | United States | $0.866B | 0.00 |
| Standard BioTools (LAB) | United States | $0.809B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.621B | 0.00 |
| Talkspace (TALK) | United States | $0.588B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.357B | 0.00 |
| Clover Health Investments (CLOV) | United States | $0.332B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.326B | 0.00 |
| Pulmonx (LUNG) | United States | $0.304B | 0.00 |
| Augmedix (AUGX) | United States | $0.186B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.185B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.185B | 0.00 |
| American Well (AMWL) | United States | $0.166B | 0.00 |
| MSP Recovery (LIFW) | United States | $0.158B | 0.00 |
| TruBridge (TBRG) | United States | $0.129B | 5.49 |
| Outset Medical (OM) | United States | $0.106B | 0.00 |
| 111 (YI) | China | $0.092B | 0.00 |
| SHL Telemedicine (SHLT) | Israel | $0.082B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.076B | 0.00 |
| Zepp Health (ZEPP) | China | $0.055B | 0.00 |
| HeartBeam (BEAT) | United States | $0.051B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.046B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.036B | 0.00 |
| Movano (MOVE) | United States | $0.029B | 0.00 |
| Cue Health (HLTH) | United States | $0.026B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.024B | 0.00 |
| Akili (AKLI) | United States | $0.021B | 0.00 |
| ETAO (ETAO) | United States | $0.020B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.019B | 0.00 |
| CareCloud (CCLD) | United States | $0.019B | 0.00 |
| Centogene (CNTG) | Germany | $0.015B | 0.00 |
| Biotricity (BTCY) | United States | $0.011B | 0.00 |
| Transgenomic (PRPO) | United States | $0.010B | 0.00 |
| Syra Health (SYRA) | United States | $0.007B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.007B | 0.00 |
| HeartSciences (HSCS) | United States | $0.007B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.007B | 0.00 |
| Zhongchao (ZCMD) | China | $0.003B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
| Motus GI Holdings (MOTS) | United States | $0.001B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.000B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.000B | 0.00 |